Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos

Anti-Cancer Drug Design

Volumn 14, Issue 4, 1999, Pages 355-365

  Izbicka, Elzbieta ^f   Nishioka, David ^a   Marcell, Vanessa ^a   Raymond, Eric ^f   Davidson, Karen K ^b   Lawrence, Richard A ^f   Wheelhouse, Richard T ^c,d   Hurley, Laurence H ^c   Wu, Roy S ^e   Von Hoff, Daniel D ^f  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f CTRC Institute for Drug Development   (United States)

Author keywords

G quadruplex; Porphyrin; Sea urchin; Telomerase; Telomere

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORESCEIN; GUANINE; NUCLEOTIDYLTRANSFERASE INHIBITOR; PORPHYRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TELOMERASE; ZIDOVUDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME; CONTROLLED STUDY; DRUG DNA INTERACTION; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; SEA URCHIN; TELOMERE;

ANIMALS; CELL DIVISION; CHROMOSOMES; ENZYME INHIBITORS; OLIGONUCLEOTIDES, ANTISENSE; PORPHYRINS; SEA URCHINS; TELOMERASE; TELOMERE; ZIDOVUDINE;

EID: 0032742766     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Blackburn E. (1991) Structure and function of telomeres. Nature, 350, 569.
2. Blasco M., Lee H., Hande P., Samper E., Lansdorp P., DePinho R., Greider C. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25.
3. Burger A., Double J., Newell D. (1997) Inhibition of telomerase activity in human testicular cancer cells. European Journal of Cancer, 33, 638.
4. Czihak C. (1975) The Sea Urchin Embryo Biochemistry and Morphogenesis. Springer: New York.
5. Fletcher T., Salazar M., Chen S. (1996) Human telomerase inhibition by 7-deaza-2′-deoxypurine nucleoside triphosphates. Biochemistry, 35, 15611.
6. Gong Z., Brandhorst B. (1988) Autogenous regulation of tubulin synthesis via RNA stability during sea urchin embryogenesis. Development, 102, 31.
7. Harvey E.B. (1956) The American Arbacia and Other Sea Urchins. Princeton University Press: Princeton, NJ.
8. Izbicka E., Wheelhouse R.T., Raymond E., Davidson K.K., Lawrence R.A., Sun D., Windle B.E., Hurley L.H., Von Hoff D.D. (1999) Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Research, 59, 639.
9. Kim N.W., Piatyszek A.M., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011.
10. Kirk K., Harmon B., Reichardt I., Sedat J., Blackburn E. (1997) Block in anaphase chromosome separation caused by telomerase template mutation. Science, 275, 1478.
11. Lee H., Blasco M., Gottlieb G., Horner J., Greider C., Depinho R. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature, 392, 569.
12. Lejnine S., Makarov V., Langmore J. (1995) Conserved nucleoprotein structure at the ends of vertebrate and invertebrate chromosomes. Proceedings of the National Academy of Sciences, USA, 92, 2393.
13. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., Cech T. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science, 276, 561.
14. Mantell L.L., Greider C.W. (1994) Telomerase activity in germline and embryonic cells of Xenopus. EMBO Journal, 13, 3211.
15. Mata J.E., Joshi S.S., Paten B., Pirruccello S.J., Jackson J.D., Elias N., Paige T.J., Medlin K.L., Iveson P.L. (1997) A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicology and Applied Pharmacy, 144, 189.
16. Megonigal M., Fertala J., Bjornsti M. (1997) Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death. Journal of Biological Chemistry, 272, 12801.
17. Mergny J.L., Hélène C. (1998) G-Quadruplex DNA: a target for drug design. Nature Medicine, 4, 1366.
18. Morin G. (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59, 521.
19. Morin G. (1995) Is telomerase a universal cancer target? Journal of the National Cancer Institute, 87, 859.
20. Morton R., Nishioka D. (1983) Effects of cytochalasin B on the cortex of the unfertilized sea urchin egg. Cell Biology International Reports, 7, 835.
21. Nishioka D., Balczon R., Schatten G. (1984a) Relationships between DNA synthesis and mitotic events in fertilized sea urchin eggs: aphidicolin inhibits DNA synthesis, nuclear breakdown and proliferation of microtubule organizing centers, but not cycles of microtubule assembly. Cell Biology International Reports. 8, 337.
22. Nishioka D., Killian C., Chacon C., Sgiagas M. (1984b) Increased uptake of thymidine in the activation of sea urchin eggs. III. Effects of aphidicolin. Journal of Cell Physiology, 118, 27.
23. Norton J.C., Piatyszek M.A., Wright W.E., Shay J.W., Corey D.R. (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnology, 14, 615.
24. Parkinson E.K. (1996) Do telomerase antagonists represent a novel anti-cancer strategy? British Journal of Cancer, 73, 1.
25. Raymond E., Sun D., Chen S.-F., Windle B., Von Hoff D. (1996a) Agents that target telomerase and telomeres. Current Opinion in Biotechnology, 7, 583.
26. Raymond E., Sun D., Izbicka E., Champlin R., Von Hoff D. (1996b) Level of processive telomerase activity in human peripheral blood progenitor cells. Annals in Oncology, 7, 5.
27. Raymond E., Sun D., Izbicka E., Mangold G., Silvas E., Windle B., Sharma S., Soda H., Lawrence R., Davidson K., Von Hoff D. (1999) Development of a human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. British Journal of Cancer, 80, 1332.
28. Salazar M., Thompson B.D., Kerwin S.M., Hurley L.H. (1996) Thermally induced DNA/RNA hybrid to G-quadruplex transitions: possible implications for telomere synthesis by telomerase. Biochemistry, 35, 16011.
29. Sharma S., Raymond E., Soda H., Sun D., Hilsenbeck S.G., Sharma A., Izbicka E., Windle B., Von Hoff D.D. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Annals of Oncology, 8, 1063.
30. Strahl C., Blackburn E.H. (1994) The effects of nucleoside analogues on telomerase and telomeres in Tetrahymena. Nucleic Acids Research, 22, 893.
31. Strahl C., Blackburn E.H. (1996) Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human tumor cell lines. Molecular and Cellular Biology, 16, 53.
32. Sun D., Hurley L., Von Hoff D. (1998) Telomerase assay using biotinylated primer extension and magnetic separation of the products. BioTechniques, 25, 1046.
33. Vacquier V.D., Mazia D. (1968a) Twinning of sand dollar embryos by means of dithiothreitol. Experimental Cell Research, 52, 209.
34. Vacquier V.D., Mazia D. (1968b) Twinning of sea urchin embryos by treatment with dithiothreitol. Experimental Cell Research, 52, 459.
35. van Steensel B., Smogorzewska A., de Lange T. (1998) TRF2 protects human telomeres from end-to-end fusions. Cell, 92, 401.
36. Wheelhouse R., Sun D., Han H., Han E, Hurley L. (1998) Cationic porphyrins as telomerase inhibitors: the interaction of tetra(N-methyl-4-pyridyl)porphine with quadruplex DNA. Journal of the American Chemical Society, 120, 3261.